In business for 125 years

Alvogen is built on the strong foundation of Norwich Pharmaceuticals (Norwich) in New York, a company with a 125-year history and an unsurpassed regulatory track record. A clear focus on continuous improvement and a long history of delivering high-quality pharmaceuticals from world-class production facilities has enabled the company to deliver exceptional value and high quality products and services. The Norwich plant, with an annual capacity of five billion tablets and capsules, is the American manufacturing base of Alvogen. A new packaging plant in Serbia, with an annual capacity of 11 million packs, is the CEE base for packaging.

The Norwich Advantage

Norwich Pharmaceuticals offers comprehensive solutions for all stages of the product lifecycle. The company is a recognized leader in full-service contract pharmaceutical development and manufacturing. As a single-source provider, Norwich offers customers greater flexibility, resources and speed that result in a streamlined progression from product development and clinical

research to scale-up and through commercial manufacturing. Founded upon our reputation for quality, compliance and dependability, we strive to deliver uncommon value and be the first choice of customers for pharmaceutical contract services.

State-of-the-art facility

Norwich’s manufacturing facility is a 375,000 square-foot operation containing fully qualified GMP equipment and capabilities. All manufacturing suites are equipped with HEPA filters to prevent cross-contamination between rooms. For maximum environmental control, our Honeywell® system monitors pressure differentials, temperature and humidity levels throughout the manufacturing and warehouse facilities.

With capabilities from clinical to commercial manufacturing, Norwich can qualify clinical trial and commercial production in the same facility, resulting in reduced drug development times and faster regulatory approvals.